Immunomodulation with recombinant interferon-gamma1b in pulmonary tuberculosis.

Immunomodulation with recombinant interferon-gamma1b in pulmonary tuberculosis.

BACKGROUND:Current treatment regimens for pulmonary tuberculosis require at least 6 months of therapy. Immune adjuvant therapy with recombinant interferon-gamma1b (rIFN-gammab) may reduce pulmonary inflammation and reduce the period of infectivity by promoting earlier sputum clearance. METHODOLOGY/P...

Full description

Bibliographic Details
Main Authors: Rod Dawson, Rany Condos, Doris Tse, Maryann L Huie, Stanley Ress, Chi-Hong Tseng, Clint Brauns, Michael Weiden, Yoshihiko Hoshino, Eric Bateman, William N Rom
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2009-09-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2737621?pdf=render

Internet

http://europepmc.org/articles/PMC2737621?pdf=render

Similar Items